Introduction

Cancer development and spread involve complex processes that cannot be modelled for basic or translational science using conventional 2D cultures of tumour cells. Concerted multidisciplinary efforts to improve experimental systems have led to the emergence of novel approaches involving 3D culture formats and bioengineered materials that more accurately reflect the biochemical, spatial and mechanical properties of tumours in their tissue environment.

Following three very successful editions of the conference in Berlin, this virtual conference will focus on the latest advances in 3D-based cellular models and emerging topics in the areas of cell architecture, mechanobiology, the immune microenvironment, high level imaging and high-content analysis for cancer therapeutics. The conference format is designed to encourage networking in order to develop approaches that translate to outcomes. 

Who should attend?

Faculty, postdocs, and trainees interested in the techniques and applications of 3D culture at the intersection of cancer biology, engineering, and drug development.

Industry scientists interested in identifying promising platforms for drug discovery and targets for novel therapies.

Topics to be covered

• Cell adhesion, migration and mechanics
• Imaging tumour invasion in 3D
• 3D in vitro systems for drug development and clinical applications
• Multicellular interactions and the immune microenvironment

Scientific Programme Committee

• Emmanuel Donnadieu, Institut Cochin, France
• Andrew Ewald, Johns Hopkins School of Medicine, USA
• Peter Friedl, Radboud UMC, Netherlands
• Henriëtte Lans, MIMETAS, Netherlands
• Valerie Weaver, UCSF, USA

Contact

If you have any queries that are not answered on this webpage, please contact us using the details below.

Claire Sullivan
Conference Officer
claire.sullivan@eacr.org

Sign-up for updates